한글목차

세계 연속 혈당 모니터링(CGM) 시스템 시장 규모는 기술 발전과 당뇨병 유병률 증가에 힘입어 향후 몇 년 동안 9.3%의 연평균 성장률(CAGR)로 꾸준히 성장하여 2025년에는 131억 4,000만 달러, 2032년에는 244억 9,000만 달러에 달할 것으로 예상됩니다. CGM 시스템은 당뇨병 관리에 혁명을 일으켜 혈당 변동에 대한 실시간 인사이트를 제공하고 사전 예방적 치료를 가능하게 하는 등 당뇨병 관리에 혁명을 일으킬 것으로 예상됩니다.

연속 혈당 모니터링 시스템은 첨단 센서를 사용하여 손가락을 자주 찔러 검사하지 않고도 정확한 실시간 혈당 데이터를 제공합니다. 이 혁신적인 접근 방식은 환자와 의료진의 당뇨병 관리 능력을 향상시켰습니다. CGM 시스템의 장점, 향상된 혈당 조절 능력, 당뇨병 관리의 편의성에 대한 인식이 높아짐에 따라 이러한 시스템의 채택이 증가하고 있으며, CGM 시스템과 디지털 건강 생태계와의 통합은 그 수요를 더욱 증가시키고 있습니다.

연속 혈당 모니터링 시스템 시장은 디지털 건강 통합, 맞춤형 의료, 확대되는 지역 시장으로 인해 큰 기회가 생겨나면서 혁신적인 성장을 이룰 준비가 되어 있습니다. 기술 발전과 의료 정책의 지원은 혁신을 촉진하고 효과적인 당뇨병 관리 솔루션에 대한 광범위한 접근을 보장하기 위해 시장 궤도를 계속 형성할 것입니다.

센서 기술의 끊임없는 혁신으로 CGM 시스템의 정확성, 신뢰성, 사용 편의성이 향상되고 있습니다. 인공지능과 머신러닝에 의한 데이터 분석 기능의 향상은 더 나은 당뇨병 관리를 위한 실용적인 인사이트를 제공합니다. 앉아서 생활하는 습관과 건강에 해로운 식습관의 증가로 인해 전 세계적으로 당뇨병 환자가 증가하고 있으며, 이에 따라 효과적인 혈당 모니터링 솔루션이 절실히 요구되고 있습니다. 북미와 같은 지역에서는 종합적인 상환 이니셔티브와 지원적인 규제 프레임워크가 CGM 기기의 채택을 촉진하고 있습니다.

이 보고서는 세계 연속 혈당 모니터링 시스템 시장에 대해 조사했으며, 시장 개요와 함께 구성요소별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 생산량과 무역 통계, 2019-2023년

제4장 가격 분석, 2019-2023년

제5장 세계의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

• 세계의 연속 혈당 모니터링 시스템 시장 전망, 구성요소별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 연속 혈당 모니터링 시스템 시장 전망, 최종사용자별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 연속 혈당 모니터링 시스템 시장 전망, 지역별, 금액(10억 달러), 수량(100만 대), 2019-2032년

제6장 북미의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

제7장 유럽의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

제8장 아시아태평양의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

제9장 라틴아메리카의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

제10장 중동 및 아프리카의 연속 혈당 모니터링 시스템 시장 전망, 2019-2032년

제11장 경쟁 구도

• 제조업체별과 최종사용자별 히트맵
• 기업 시장 점유율 분석, 2022년
• 경쟁 대시보드
• 기업 개요
  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature's Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature's Way Products
  • Abbott
  • Natural Immunogenics

제12장 부록

영문목차

The global continuous glucose monitoring (CGM) systems market is set to witness significant growth in the coming years, driven by technological advancements and increasing diabetes prevalence. Forecasted to expand at a robust CAGR of 9.3%, the market is projected to achieve a valuation of $13.14 billion by 2025 and $24.49 billion by 2032. CGM systems have revolutionized diabetes management, offering real-time insights into glucose fluctuations and enabling proactive care.

Market Insights

Continuous glucose monitoring systems utilize advanced sensors to provide accurate, real-time glucose data without the need for frequent finger stick tests. This innovative approach has enhanced the ability of patients and healthcare providers to manage diabetes effectively. The adoption of these systems is being propelled by growing awareness of their benefits, improved glycemic control capabilities, and convenience in diabetes management. The integration of CGM systems with digital health ecosystems has further amplified their demand.

The continuous glucose monitoring systems market is poised for transformative growth, with significant opportunities emerging in digital health integration, personalized medicine, and expanding regional markets. Technological advancements and supportive healthcare policies will continue to shape the trajectory of the market, driving innovation and ensuring broader access to effective diabetes management solutions.

Key Market Drivers

• Technological Advancements: Continuous innovation in sensor technology has enhanced the accuracy, reliability, and user-friendliness of CGM systems. Improved data analytics capabilities, powered by artificial intelligence and machine learning, provide actionable insights for better diabetes management.
• Increasing Diabetes Prevalence: A rise in sedentary lifestyles and unhealthy dietary habits has escalated diabetes cases globally, creating a pressing need for effective glucose monitoring solutions.
• Favorable Government Policies: Comprehensive reimbursement initiatives and supportive regulatory frameworks in regions like North America have encouraged the adoption of CGM devices.

Business Opportunities

• Integration with Digital Health Platforms: CGM devices are increasingly being integrated with health apps, electronic health records (EHRs), and telehealth services, enabling comprehensive diabetes care and personalized interventions.
• Emerging Markets in Asia Pacific: The rapidly growing diabetic population and healthcare infrastructure advancements in Asia Pacific present lucrative opportunities for CGM device manufacturers.
• Expansion of Home Care Diagnostics: With a growing preference for decentralized healthcare, home care diagnostics is becoming a key segment, offering convenience and real-time glucose monitoring.

Regional Analysis

• North America: The region dominates the global CGM market, supported by robust healthcare infrastructure, high diabetes prevalence, and significant investments in research and development. Favorable reimbursement policies further boost market growth.
• Asia Pacific: Expected to register the fastest CAGR through 2032, the region's market growth is driven by an expanding diabetic population and increased adoption of advanced healthcare technologies in countries like China and India.
• Europe: The market benefits from supportive government policies and rising awareness of advanced diabetes management solutions among healthcare providers and patients.

Key Players in the Market

Leading companies are implementing strategies to strengthen their market position:

• Dexcom: Known for its advancements in sensor technology, offering devices with enhanced accuracy and longer operational durations.
• Medtronic: Provides integrated diabetes management solutions combining CGM and insulin delivery systems.
• Abbott Laboratories: Sets a benchmark for ease of use and affordability with its FreeStyle Libre system. Other notable players include Nature's Way Products, GNC Holdings, Banyan Botanicals, Nutramax Laboratories, and more.

Some key companies are:

• Herbalife Nutrition
• GNC Holdings
• NOW Health
• Nutramax Laboratories
• Nature's Bounty
• Banyan Botanicals
• Source Naturals
• Nutramarks Inc
• Nature's Way Products
• Abbott
• Natural Immunogenics

Market Segmentation

• By Component: Transmitters and Monitors Sensors Insulin Pumps
• By End User: Home Care Diagnostics Hospitals ICU/Critical Care
• By Region: North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Continuous Glucose Monitoring Systems Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Volume and Value, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. Covid-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. Pestle Analysis

3. Production Output and Trade Statistics, 2019 - 2023

• 3.1. Global Continuous Glucose Monitoring Systems Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2023
  • 3.1.1. North America
  • 3.1.2. Europe
  • 3.1.3. Asia Pacific
  • 3.1.4. Latin America
  • 3.1.5. Middle East and Africa

4. Price Analysis, 2019 - 2023

• 4.1. Global Average Price Analysis, by Component, US$ Per Unit, 2019 - 2023
• 4.2. Prominent Factor Affecting Continuous Glucose Monitoring Systems Prices
• 4.3. Global Average Price Analysis, by Region, US$ Per Unit, 2019 - 2023

5. Global Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 5.1. Global Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Transmitters and Monitors
    • 5.1.1.2. Sensors
    • 5.1.1.3. Insulin Pump
• 5.2. Global Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Home Care Diagnostics
    • 5.2.1.2. Hospitals
    • 5.2.1.3. ICU/Critical Care
• 5.3. Global Continuous Glucose Monitoring Systems Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. North America
    • 5.3.1.2. Europe
    • 5.3.1.3. Asia Pacific
    • 5.3.1.4. Latin America
    • 5.3.1.5. Middle East & Africa

6. North America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 6.1. North America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Transmitters and Monitors
    • 6.1.1.2. Sensors
    • 6.1.1.3. Insulin Pump
• 6.2. North America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Home Care Diagnostics
    • 6.2.1.2. Hospitals
    • 6.2.1.3. ICU/Critical Care
  • 6.2.2. BPS Analysis/Market Attractiveness Analysis
• 6.3. North America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. U.S. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.2. U.S. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.3. Canada Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.4. Canada Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.2. Bps Analysis/Market Attractiveness Analysis

7. Europe Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 7.1. Europe Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Transmitters and Monitors
    • 7.1.1.2. Sensors
    • 7.1.1.3. Insulin Pump
• 7.2. Europe Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Home Care Diagnostics
    • 7.2.1.2. Hospitals
    • 7.2.1.3. ICU/Critical Care
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Europe Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Germany Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.2. Germany Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.3. U.K. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.4. U.K. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.5. France Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.6. France Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.7. Italy Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.8. Italy Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.9. Turkey Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.10. Turkey Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.11. Russia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.12. Russia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.13. Rest Of Europe Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.14. Rest Of Europe Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.2. Bps Analysis/Market Attractiveness Analysis

8. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 8.1. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Transmitters and Monitors
    • 8.1.1.2. Sensors
    • 8.1.1.3. Insulin Pump
• 8.2. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Home Care Diagnostics
    • 8.2.1.2. Hospitals
    • 8.2.1.3. ICU/Critical Care
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. China Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.2. China Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.3. Japan Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.4. Japan Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.5. South Korea Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.6. South Korea Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.7. India Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.8. India Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.9. Southeast Asia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.10. Southeast Asia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.11. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.12. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 9.1. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Transmitters and Monitors
    • 9.1.1.2. Sensors
    • 9.1.1.3. Insulin Pump
• 9.2. Latin America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Home Care Diagnostics
    • 9.2.1.2. Hospitals
    • 9.2.1.3. ICU/Critical Care
  • 9.2.2. BPS Analysis/Market Attractiveness Analysis
• 9.3. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. Brazil Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.2. Brazil Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.3. Mexico Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.4. Mexico Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.5. Argentina Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.6. Argentina Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.7. Rest Of Latin America Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.8. Rest Of Latin America Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.2. Bps Analysis/Market Attractiveness Analysis

10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

• 10.1. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 10.1.1. Key Highlights
    • 10.1.1.1. Transmitters and Monitors
    • 10.1.1.2. Sensors
    • 10.1.1.3. Insulin Pump
• 10.2. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 10.2.1. Key Highlights
    • 10.2.1.1. Home Care Diagnostics
    • 10.2.1.2. Hospitals
    • 10.2.1.3. ICU/Critical Care
  • 10.2.2. BPS Analysis/Market Attractiveness Analysis
• 10.3. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 10.3.1. Key Highlights
    • 10.3.1.1. GCC Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.2. GCC Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.3. South Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.4. South Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.5. Egypt Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.6. Egypt Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.7. Nigeria Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.8. Nigeria Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.9. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1.10. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 10.3.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

• 11.1. Manufacturer Vs by End User Heatmap
• 11.2. Company Market Share Analysis, 2022
• 11.3. Competitive Dashboard
• 11.4. Company Profiles
  • 11.4.1. Herbalife Nutrition
    • 11.4.1.1. Company Overview
    • 11.4.1.2. Component Portfolio
    • 11.4.1.3. Financial Overview
    • 11.4.1.4. Business Strategies and Development
  • 11.4.2. GNC Holdings
    • 11.4.2.1. Company Overview
    • 11.4.2.2. Component Portfolio
    • 11.4.2.3. Financial Overview
    • 11.4.2.4. Business Strategies and Development
  • 11.4.3. NOW Health
    • 11.4.3.1. Company Overview
    • 11.4.3.2. Component Portfolio
    • 11.4.3.3. Financial Overview
    • 11.4.3.4. Business Strategies and Development
  • 11.4.4. Nutramax Laboratories
    • 11.4.4.1. Company Overview
    • 11.4.4.2. Component Portfolio
    • 11.4.4.3. Financial Overview
    • 11.4.4.4. Business Strategies and Development
  • 11.4.5. Nature's Bounty
    • 11.4.5.1. Company Overview
    • 11.4.5.2. Component Portfolio
    • 11.4.5.3. Financial Overview
    • 11.4.5.4. Business Strategies and Development
  • 11.4.6. Banyan Botanicals
    • 11.4.6.1. Company Overview
    • 11.4.6.2. Component Portfolio
    • 11.4.6.3. Financial Overview
    • 11.4.6.4. Business Strategies and Development
  • 11.4.7. Source Naturals
    • 11.4.7.1. Company Overview
    • 11.4.7.2. Component Portfolio
    • 11.4.7.3. Financial Overview
    • 11.4.7.4. Business Strategies and Development
  • 11.4.8. Nutramarks Inc
    • 11.4.8.1. Company Overview
    • 11.4.8.2. Component Portfolio
    • 11.4.8.3. Financial Overview
    • 11.4.8.4. Business Strategies and Development
  • 11.4.9. Nature's Way Products
    • 11.4.9.1. Company Overview
    • 11.4.9.2. Component Portfolio
    • 11.4.9.3. Financial Overview
    • 11.4.9.4. Business Strategies and Development
  • 11.4.10. Abbott
    • 11.4.10.1. Company Overview
    • 11.4.10.2. Component Portfolio
    • 11.4.10.3. Financial Overview
    • 11.4.10.4. Business Strategies and Development
  • 11.4.11. Natural Immunogenics
    • 11.4.11.1. Company Overview
    • 11.4.11.2. Component Portfolio
    • 11.4.11.3. Financial Overview
    • 11.4.11.4. Business Strategies and Development

12. Appendix

• 12.1. Research Methodology
• 12.2. Report Assumptions
• 12.3. Acronyms And Abbreviations